Source: Annual Congress 2006 - Clinical problems: miscellaneous II
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Okumus, G. Kuran, R. Unver, L. Tabak, F. Erkan, H. Issever, O. Arseven (Istanbul, Turkey). Quality of life in patients with venous thromboembolism. Eur Respir J 2006; 28: Suppl. 50, 448

Member's Comments

No comment yet.

Related content which might interest you: Quality of life in patients with chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2016; 48: 526-537 Year: 2016 Quality of life in Russian patients with COPD complicated by pulmonary artery hypertension Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008 Evaluation of quality life indices in patients after pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Risk factors in patients with venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002 Quality of life and physical functioning in chronic thromboembolic pulmonary hypertension (CTEPH):  the impact of treatment Source: International Congress 2017 – PAH and CTEPH Year: 2017 Health-related quality of life in patients with pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018 Year: 2018 Venous thromboembolism in patients immobilised at home Source: Eur Respir J 2015; 45: 1728-1731 Year: 2015 Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016 Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review Source: Eur Respir J 2015; 45: 201-210 Year: 2015 Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis? Source: Eur Respir J 2016; 47: 369-373 Year: 2016 Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial Source: Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017 Year: 2018 Clinical presentation and outcome of venous thromboembolism in COPD Source: Eur Respir J 2012; 39: 862-868 Year: 2012 Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study Source: Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021 Year: 2022 Jugular venous ultrasound predicts outcomes in pulmonary hypertension outpatients Source: Eur Respir J, 59 (1) 2102591; 10.1183/13993003.02591-2021 Year: 2022 Asthma and risk of pulmonary thromboembolism Source: Eur Respir J 2014; 43: 1534-1535 Year: 2014 EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013